Dr. Peter Christopher Mccutcheon, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 436 Fifth St., Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-7325 |
Dr. Olivia Rose Rhines, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Kotzebue, AK 99752 Phone: 907-442-3321 |
Zazell Staheli Cummings, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Kotzebue, AK 99752 Phone: 907-442-7326 |
News Archive
Results of a new study by UCLA researchers has found that a groundbreaking new triple combination therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK inhibitor or BRAF inhibitor + immunotherapy combos alone, and with increased immune response and fewer side effects.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it, a study headed by Mayo Clinic shows. The findings, published early online in the journal Cancer, may play an important role for researchers as they study the use of existing medications to treat different or new diseases.
Now, an international team of thirty researchers from Sweden, Italy, Germany, the USA, and China aimed to determine the longevity of the immune response against SARS-CoV-2, particularly the specific memory B-cell and T-cell responses over time in convalescent COVID-19 patients.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
› Verified 4 days ago